News
VYNE Therapeutics will terminate its Phase IIb trial of topical Repibresib gel in nonsegmental vitiligo after failing to meet ...
In this video interview, Michael Miller, chief operating officer at Quanterix, highlights neurology and oncology as two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback